Key Insights

Highlights

Success Rate

75% trial completion

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 62/100

Termination Rate

11.1%

1 terminated out of 9 trials

Success Rate

75.0%

-11.6% vs benchmark

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed with results

Key Signals

75% success

Data Visualizations

Phase Distribution

7Total
Not Applicable (5)
P 3 (1)
P 4 (1)

Trial Status

Completed3
Recruiting2
Not Yet Recruiting2
Terminated1
Unknown1

Trial Success Rate

75.0%

Benchmark: 86.6%

Based on 3 completed trials

Clinical Trials (9)

Research Network

Activity Timeline